Clinical Trial Update: Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of umbilical cord-derived mesenchymal stem cells for steroid-resistant acute graft-versus-host disease aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• UC-MSCs (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Graft Vs Host Disease | Phase 3 | Status: COMPLETED